aztreonam has been researched along with Necrotizing Pyelonephritis in 8 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-two evaluable patients suffering from UTI were randomly treated with parenteral Aztreonam (1 g OD in cystitis and 1 g BID in pyelonephritis) or oral Norfloxacin (400 mg BID)." | 9.06 | [Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients]. ( De Rose, AF; Germinale, F; Puppo, P, 1989) |
| "We performed a comparative study between the monobactam antibiotic aztreonam and the aminoglycoside tobramycin in patients diagnosed as having acute pyelonephritis." | 9.06 | [Aztreonam versus tobramycin in acute pyelonephritis. A comparative study]. ( David Vera, C; Gallego, J; Gobernado, M; Jiménez Cruz, JF; Llopis, B; Ruiz, JL; Server, G; Vidal, J, 1989) |
| "Eighty-two evaluable patients suffering from UTI were randomly treated with parenteral Aztreonam (1 g OD in cystitis and 1 g BID in pyelonephritis) or oral Norfloxacin (400 mg BID)." | 5.06 | [Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients]. ( De Rose, AF; Germinale, F; Puppo, P, 1989) |
| "We performed a comparative study between the monobactam antibiotic aztreonam and the aminoglycoside tobramycin in patients diagnosed as having acute pyelonephritis." | 5.06 | [Aztreonam versus tobramycin in acute pyelonephritis. A comparative study]. ( David Vera, C; Gallego, J; Gobernado, M; Jiménez Cruz, JF; Llopis, B; Ruiz, JL; Server, G; Vidal, J, 1989) |
| "Aztreonam (AZT) was evaluated for its clinical efficacy in a total of 10 cases, namely 3 cases of endometritis, 6 cases of intrapelvic infections, 1 case of puerperal pyelonephritis." | 3.67 | [Clinical evaluation of aztreonam in the field of obstetrics and gynecology]. ( Ijuin, H, 1985) |
| "Aztreonam was used for a year to treat 106 hospitalized patients with a total of 131 documented gram-negative infections." | 1.27 | Treatment of serious gram-negative infections with aztreonam. ( Bollinger, M; Darji, TB; Greenberg, RN; Luppen, KL; McMillian, R; Noorani, AA; Reilly, PM; Wolk, SM, 1984) |
| "Carumonam was intermediate between ceftazidime and aztreonam as to the activity against Pseudomonas aeruginosa." | 1.27 | Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic. ( Angehrn, P, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenberg, RN | 1 |
| Reilly, PM | 1 |
| Luppen, KL | 1 |
| McMillian, R | 1 |
| Bollinger, M | 1 |
| Wolk, SM | 1 |
| Darji, TB | 1 |
| Noorani, AA | 1 |
| Ladefoged, J | 1 |
| Sengoku, K | 1 |
| Shimizu, T | 1 |
| Haga, H | 1 |
| Inoue, R | 1 |
| Yamazaki, T | 1 |
| Mizoguchi, H | 1 |
| Torii, Y | 1 |
| Sagawa, T | 1 |
| Saitou, S | 1 |
| Puppo, P | 1 |
| Germinale, F | 1 |
| De Rose, AF | 1 |
| Gallego, J | 1 |
| Jiménez Cruz, JF | 1 |
| Gobernado, M | 1 |
| Llopis, B | 1 |
| Vidal, J | 1 |
| Server, G | 1 |
| Ruiz, JL | 1 |
| David Vera, C | 1 |
| Kafetzis, D | 1 |
| Papadimitriou, G | 1 |
| Stavridis, C | 1 |
| Sinaniotis, C | 1 |
| Papoulias, G | 1 |
| Ijuin, H | 1 |
| Angehrn, P | 1 |
3 trials available for aztreonam and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Aztreonam for renal graft pyelonephritis.
Topics: Adult; Ampicillin; Aztreonam; Female; Gram-Negative Bacterial Infections; Humans; Kidney Transplanta | 1991 |
[Aztreonam vs norfloxacin: a comparative study of the treatment of urinary tract infections in ambulatory and hospitalized patients].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Aztreonam; Clinical Trials as Topic; Cystitis; F | 1989 |
[Aztreonam versus tobramycin in acute pyelonephritis. A comparative study].
Topics: Acute Disease; Adult; Aged; Aztreonam; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Ma | 1989 |
5 other studies available for aztreonam and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Treatment of serious gram-negative infections with aztreonam.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Evaluation; En | 1984 |
[Pharmacokinetic and clinical studies on aztreonam in perinatal period].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Chorioamnionitis; Female; Fetal Blood; Genit | 1990 |
Treatment of pyelonephritis with aztreonam: kinetic study in children.
Topics: Aztreonam; Child; Child, Preschool; Escherichia coli Infections; Humans; Infant; Pseudomonas Infecti | 1987 |
[Clinical evaluation of aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Humans; M | 1985 |
Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Enterobacteriaceae; Escherichia coli Infections | 1985 |